AbbVie is buying Botox producer Allergan for about $63 billion

AbbVie is buying Allergan for $188.24 per share, at a premium of almost 45 percent. Wall Street Journal reporter who broke the story, Jonathan Rockoff, calls into the "Squawk Box" to discuss the story.